Furiex Pharmaceuticals, Inc. 4
4 · Furiex Pharmaceuticals, Inc. · Filed Apr 11, 2012
Insider Transaction Report
Form 4
COVINGTON PAUL S
Senior VP-Clinical Operations
Transactions
- Award
Stock Options (to buy)
2012-02-24+10,368→ 10,368 totalExercise: $17.80Exp: 2022-02-24→ Common Stock (10,368 underlying)
Holdings
- 2,923
Common Stock
- 37,944
Stock Options (to buy)
Exercise: $13.16Exp: 2021-10-03→ Common Stock (37,944 underlying) - 26,000
Stock Options (to buy)
Exercise: $15.00Exp: 2021-05-09→ Common Stock (26,000 underlying) - 75,691
Stock Options (to buy)
Exercise: $9.11Exp: 2020-06-17→ Common Stock (75,691 underlying)
Footnotes (4)
- [F1]The options were awarded on 2/24/2012 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
- [F2]The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
- [F3]The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
- [F4]The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.